Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
44
SAFRY Quote, Financials, Valuation and Earnings
Last price:
$54.73
Seasonality move
:
4.13%
Day range:
$53.94 - $55.00
52-week range:
$43.04 - $60.57
Dividend yield:
1.09%
P/E ratio:
51.99x
P/S ratio:
3.42x
P/B ratio:
7.63x
Volume:
203.8K
Avg. volume:
117.5K
1-year change:
27.64%
Market cap:
$91.8B
Revenue:
$25.6B
EPS (TTM):
--
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $28.1B | $19B | $17.9B | $20.6B | $25.6B | |
| Revenue Growth (YoY) | 13.17% | -32.4% | -5.73% | 14.99% | 24.36% | |
| Cost of Revenues | $15.2B | $10.3B | $9.3B | $10.7B | $13.6B | |
| Gross Profit | $12.9B | $8.7B | $8.6B | $9.9B | $12B | |
| Gross Profit Margin | 45.89% | 45.79% | 48.09% | 48.04% | 46.71% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $8.9B | $7B | $7.2B | $7B | $8.4B | |
| Operating Income | $4B | $1.7B | $1.4B | $2.9B | $3.6B | |
| Net Interest Expenses | $21.3M | $101.6M | $121.9M | $41.1M | -- | |
| EBT. Incl. Unusual Items | $3.9B | $651M | $317.1M | -$3.3B | $5.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.1B | $210.1M | $236.6M | -$731.9M | $1.3B | |
| Net Income to Company | $2.7B | $402M | $50.9M | -$2.6B | $3.7B | |
| Minority Interest in Earnings | -$72.8M | -$38.8M | -$29.6M | -$34.8M | -$82.3M | |
| Net Income to Common Excl Extra Items | $2.7B | $402M | $50.9M | -$2.6B | $3.7B | |
| Basic EPS (Cont. Ops) | $1.59 | $0.24 | $0.03 | -$1.52 | $2.23 | |
| Diluted EPS (Cont. Ops) | $1.58 | $0.23 | $0.03 | -$1.52 | $2.18 | |
| Weighted Average Basic Share | $1.7B | $1.7B | $1.7B | $1.7B | $1.7B | |
| Weighted Average Diluted Share | $1.7B | $1.8B | $1.8B | $1.8B | $1.7B | |
| EBITDA | $5.8B | $2.6B | $2.4B | -$1.5B | $6.9B | |
| EBIT | $4B | $782.3M | $452M | -$3.2B | $5.3B | |
| Revenue (Reported) | $28.1B | $19B | $17.9B | $20.6B | $25.6B | |
| Operating Income (Reported) | $4B | $1.7B | $1.4B | $2.9B | $3.6B | |
| Operating Income (Adjusted) | $4B | $782.3M | $452M | -$3.2B | $5.3B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $466.3K | $817.5K | $855.5K | |
| Other Inc / (Exp) | -- | -- | -$32.2K | -$22.8K | -$9.8K | |
| Operating Expenses | -- | -- | $538.4K | $1.4M | $1.1M | |
| Operating Income | -- | -- | -$538.4K | -$1.4M | -$1.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$618.9K | -$1.4M | -$1.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$618.9K | -$1.4M | -$1.1M | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.01 | -$0.01 | -$0.01 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.01 | -$0.01 | -$0.01 | |
| Weighted Average Basic Share | -- | -- | $86.2M | $113.9M | $117.2M | |
| Weighted Average Diluted Share | -- | -- | $86.2M | $113.9M | $117.2M | |
| EBITDA | -- | -- | -$532K | -$1.4M | -$1.1M | |
| EBIT | -- | -- | -$570.5K | -$1.5M | -$1.1M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -$538.4K | -$1.4M | -$1.1M | |
| Operating Income (Adjusted) | -- | -- | -$570.5K | -$1.5M | -$1.1M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $28B | $19B | $17.7B | $20.3B | $25.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $2.9M | $3.1M | |
| Other Inc / (Exp) | -- | -- | -$21.5K | -$10.5K | -$16.2K | |
| Operating Expenses | -- | -- | -- | $4.3M | $4.2M | |
| Operating Income | -- | -- | -- | -$4.3M | -$4.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -$4.5M | -$4.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -$4.5M | -$4.1M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -$0.03 | -$0.04 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.03 | -$0.04 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -$4.3M | -$4.1M | |
| EBIT | -- | -- | -- | -$4.4M | -$4.3M | |
| Revenue (Reported) | $28B | $19B | $17.7B | $20.3B | $25.6B | |
| Operating Income (Reported) | -- | -- | -- | -$4.3M | -$4.3M | |
| Operating Income (Adjusted) | -- | -- | -- | -$4.4M | -$4.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $10.7K | $11.1K | -- | |
| Gross Profit | -- | -- | -$10.7K | -$11.1K | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $1M | $2.9M | $3.1M | -- | |
| Other Inc / (Exp) | -- | -$21.5K | -$10.5K | -$16.2K | -- | |
| Operating Expenses | -- | $1.2M | $4.3M | $4.2M | -- | |
| Operating Income | -- | -$1.2M | -$4.3M | -$4.3M | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$1.5M | -$4.5M | -$4.1M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$1.5M | -$4.5M | -$4.1M | -- | |
| Basic EPS (Cont. Ops) | -- | -$0.02 | -$0.03 | -$0.04 | -- | |
| Diluted EPS (Cont. Ops) | -- | -$0.02 | -$0.03 | -$0.04 | -- | |
| Weighted Average Basic Share | -- | $246.7M | $431.6M | $461.6M | -- | |
| Weighted Average Diluted Share | -- | $246.7M | $431.6M | $461.6M | -- | |
| EBITDA | -- | -$1.1M | -$4.3M | -$4.1M | -- | |
| EBIT | -- | -$1.2M | -$4.4M | -$4.3M | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -$1.2M | -$4.3M | -$4.3M | -- | |
| Operating Income (Adjusted) | -- | -$1.2M | -$4.4M | -$4.3M | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.9B | $4.6B | $5.9B | $7.2B | $7.4B | |
| Short Term Investments | $160.2M | $155M | $117.8M | $259.5M | $519.5M | |
| Accounts Receivable, Net | $7.7B | $6.2B | $6.4B | $7.5B | $9.1B | |
| Inventory | $7.1B | $6.4B | $5.7B | $6.9B | $8.7B | |
| Prepaid Expenses | $122.1M | $110.7M | $118.9M | $140.5M | $206.7M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $22.5B | $22.4B | $23.3B | $26.8B | $32.5B | |
| Property Plant And Equipment | $5.7B | $5.8B | $5.1B | $4.7B | $5.2B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $5.8B | $6.2B | $5.7B | $5.4B | $5.2B | |
| Other Intangibles | $10.6B | $10.7B | $9.5B | $8.7B | $8.7B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $48B | $48.6B | $47.2B | $50.2B | $55.8B | |
| Accounts Payable | $6.3B | $4.7B | $5B | $6.1B | $8.3B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $135.5M | $140.2M | $109.8M | $113.7M | $122.7M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $25.6B | $23.4B | $22.4B | $29.5B | $34B | |
| Long-Term Debt | $3.5B | $4.9B | $5.6B | $5.6B | $5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $33.7B | $32.9B | $32.2B | $38.6B | $42.4B | |
| Common Stock | $95.2M | $104.5M | $96.2M | $91.2M | $94M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $13.9B | $15.2B | $14.5B | $11.2B | $12.8B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $422.3M | $493.2M | $485.7M | $487.9M | $564.9M | |
| Total Equity | $14.3B | $15.7B | $15B | $11.7B | $13.4B | |
| Total Liabilities and Equity | $48B | $48.6B | $47.2B | $50.2B | $55.8B | |
| Cash and Short Terms | $3.1B | $4.8B | $6.1B | $7.4B | $7.9B | |
| Total Debt | $7.3B | $7.9B | $7.4B | $6.8B | $6.6B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $4.9B | $4.7B | $6.5B | $6.7B | $6.1B | |
| Short Term Investments | $145.1M | $154.7M | $553.6M | $690.1M | $241.2M | |
| Accounts Receivable, Net | $7.6B | $6.3B | $7.3B | $9.2B | $10.2B | |
| Inventory | $7.1B | $6.3B | $6.3B | $8B | $10B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $23.3B | $22.4B | $24.1B | $29.3B | $32.3B | |
| Property Plant And Equipment | $5.6B | $5.5B | $4.8B | $4.9B | $5.4B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $5.8B | $6.1B | $5.4B | $5.4B | $5B | |
| Other Intangibles | $10.4B | $10.2B | $8.5B | $8.7B | $8.5B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $48.8B | $47.6B | $47.6B | $52.4B | $56.8B | |
| Accounts Payable | $5.9B | $5.4B | $6.2B | $7.5B | $9.6B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $126M | $119M | $105.5M | $119.5M | $129.7M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $25.6B | $21.1B | $27.8B | $31.6B | $36.6B | |
| Long-Term Debt | $4.5B | $5.8B | $5.5B | $4.9B | $3.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $34.7B | $31.6B | $37.1B | $40.3B | $44.3B | |
| Common Stock | $95.6M | $101.2M | $88.8M | $92.4M | $91.1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $438.6M | $491.5M | $459.6M | $518.4M | $545.6M | |
| Total Equity | $14.1B | $16B | $10.5B | $12.2B | $12.6B | |
| Total Liabilities and Equity | $48.8B | $47.6B | $47.6B | $52.4B | $56.8B | |
| Cash and Short Terms | $5.1B | $4.8B | $7B | $7.4B | $6.3B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.7B | $402M | $50.9M | -$2.6B | $3.7B | |
| Depreciation & Amoritzation | $1.8B | $1.8B | $1.9B | $1.7B | $1.6B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $12.3M | -- | -- | -- | -- | |
| Change in Inventories | -$660.5M | $1.2B | $350.2M | -$1.6B | -$1.6B | |
| Cash From Operations | $3.5B | $2.1B | $2.9B | $3.7B | $4.6B | |
| Capital Expenditures | $1.3B | $905.6M | $894.5M | $927M | $1.4B | |
| Cash Acquisitions | -- | $1.1M | -- | -- | -- | |
| Cash From Investing | -$1.2B | -$912.5M | -$873.2M | -$1.4B | -$1.8B | |
| Dividends Paid (Ex Special Dividend) | -$878.8M | -- | -$216.5M | -$224.6M | -$610.6M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $26.9M | $1.8B | $2.5B | $537.8M | $18.4M | |
| Long-Term Debt Repaid | -$979.6M | -$888.5M | -$1.6B | -$689.7M | -$336.7M | |
| Repurchase of Common Stock | -- | -- | -$86.4M | -$284.7M | -$1.7B | |
| Other Financing Activities | -$40.3M | -$11.4M | -- | -$17.9M | -$5.4M | |
| Cash From Financing | -$1.9B | $77.7M | -$317.1M | -$859.5M | -$2.8B | |
| Beginning Cash (CF) | $2.6B | $3B | $4.4B | $5.5B | $7.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $335.8M | $1.3B | $1.7B | $1.5B | -$10.8M | |
| Ending Cash (CF) | $2.9B | $4.3B | $6.2B | $7.1B | $7.2B | |
| Levered Free Cash Flow | $2.2B | $1.2B | $2B | $2.8B | $3.2B | |
| Period Ending | 2002-08-31 | 2003-08-31 | 2004-08-31 | 2005-08-31 | 2006-08-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $182.2M | -- | $290.7M | |
| Depreciation & Amoritzation | -- | -- | $261.9M | $297.4M | $331.2M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | $233.6M | $95K | $5.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | $1.5B | $1.7B | $4B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | $515.6M | $538M | $547.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$392.5M | -$402.1M | -$457.2M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | $65.7M | $55M | $58.6M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -$737K | $21.3M | $32.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.5B | $2.1B | $2.8B | $3.7B | $4.6B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get SAFRY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SAFRY
Sector
P/E ratio
51.99x
17.94x
PEG ratio
--
0.34x
P/B ratio
7.63x
1.76x
Price / LTM sales
3.42x
0.97x
Growth Metrics
SAFRY
Sector
Revenue growth
--
1.77%
Earnings growth
--
1.67%
Revenue (5-year growth)
0.62%
4.31%
Earnings forecast
--
$0.46
Profitability
SAFRY
Sector
Profitability FY 2023
$12B
$434.2M
Return on invested capital
--
5.93%
Return on assets
--
3.69%
Return on equity
--
8.87%
Earnings Date
Last Earnings Date
Jul
31
Next Earnings Date
Feb
14
Estimated Next Earnings Date
Oct
30
Balance Sheet
SAFRY
Sector
Total cash
$6.3B
$170.4M
Short term investments
$519.5M
$46.5M
Total assets
$55.8B
$2.1B
Long term debt
--
$147.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
